Recruiting Multiple Myeloma Studies in Milwaukee
About Multiple Myeloma Clinical Trials in Milwaukee
Multiple myeloma is a cancer of plasma cells in the bone marrow that produce abnormal antibodies. It can cause bone damage, kidney problems, and immune deficiency. Treatments have advanced significantly with proteasome inhibitors, immunomodulatory drugs, and CAR-T cell therapy.
There are currently 12 multiple myeloma clinical trials recruiting participants in Milwaukee, WI. These studies are seeking a combined 1,745 participants. Research is being sponsored by University of Alabama at Birmingham, TScan Therapeutics, Inc., Medical College of Wisconsin and 5 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Multiple Myeloma Clinical Trials in Milwaukee — FAQ
Are there multiple myeloma clinical trials in Milwaukee?
Yes, there are 12 multiple myeloma clinical trials currently recruiting in Milwaukee, WI. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Milwaukee?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Milwaukee research site will contact you about next steps.
Are clinical trials in Milwaukee free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Milwaukee studies also compensate for your time and travel.
What multiple myeloma treatments are being tested?
The 12 active trials in Milwaukee are testing new therapies including novel drugs, biologics, and treatment approaches for multiple myeloma.
Data updated September 2, 2026 from ClinicalTrials.gov